Related references
Note: Only part of the references are listed.Histopathologic Changes and SARS-CoV-2 Immunostaining in the Lung of a Patient With COVID-19
Huilan Zhang et al.
ANNALS OF INTERNAL MEDICINE (2020)
Modelling pancreatic β-cell inflammation in zebrafish identifies the natural product wedelolactone for human islet protection
Luis Fernando Delgadillo-Silva et al.
DISEASE MODELS & MECHANISMS (2019)
High Mobility Group Box-1 (HMGB1): A Potential Target in Therapeutics
Eyaldeva C. Vijayakumar et al.
CURRENT DRUG TARGETS (2019)
The Janus face of HMGB1 in heart disease: a necessary update
Angela Raucci et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2019)
Exosomes Derived From Mesenchymal Stem Cells Modulate miR-126 to Ameliorate Hyperglycemia-Induced Retinal Inflammation Via Targeting HMGB1
Wei Zhang et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2019)
Global aetiology and epidemiology of type 2 diabetes mellitus and its complications
Yan Zheng et al.
NATURE REVIEWS ENDOCRINOLOGY (2018)
A study of the lipid-mediated dimerization of the RAGE TM plus JM domains by molecular dynamic simulations
Jialin Chen et al.
CHINESE CHEMICAL LETTERS (2018)
PKA regulates HMGB1 through activation of IGFBP-3 and SIRT1 in human retinal endothelial cells cultured in high glucose
Li Liu et al.
INFLAMMATION RESEARCH (2018)
Pathophysiology of peripheral arterial disease in diabetes mellitus
Shao-ling Yang et al.
JOURNAL OF DIABETES (2017)
HMGB1 siRNA can reduce damage to retinal cells induced by high glucose in vitro and in vivo
Shuang Jiang et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2017)
Non-oxidizable HMGB1 induces cardiac fibroblasts migration via CXCR4 in a CXCL12-independent manner and worsens tissue remodeling after myocardial infarction
Stefania Di Maggio et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2017)
Serum high mobility group box-1 and osteoprotegerin levels are associated with peripheral arterial disease and critical limb ischemia in type 2 diabetic subjects
Silvia Giovannini et al.
CARDIOVASCULAR DIABETOLOGY (2017)
Platelet-derived high-mobility group box 1 promotes recruitment and suppresses apoptosis of monocytes
Sebastian Vogel et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Disulfide HMGB1 derived from platelets coordinates venous thrombosis in mice
Konstantin Stark et al.
BLOOD (2016)
The redox state of the alarmin HMGB1 is a pivotal factor in neuroinflammatory and microglial priming: A role for the NLRP3 inflammasome
Matthew G. Frank et al.
BRAIN BEHAVIOR AND IMMUNITY (2016)
Adiponectin, TNF-α and inflammatory cytokines and risk of type 2 diabetes: A systematic review and meta-analysis
Chenxiao Liu et al.
CYTOKINE (2016)
HMGB1 facilitates hypoxia-induced vWF upregulation through TLR2-MYD88-SP1 pathway
Bandana Singh et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2016)
Dioscin reduces lipopolysaccharide-induced inflammatory liver injury via regulating TLR4/MyD88 signal pathway
Hong Yao et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2016)
High Mobility Group Box-1: A Missing Link between Diabetes and Its Complications
Han Wu et al.
MEDIATORS OF INFLAMMATION (2016)
BONE MARROW STROMAL CELLS INHIBITS HMGB1-MEDIATED INFLAMMATION AFTER STROKE IN TYPE 2 DIABETIC RATS
J. Hu et al.
NEUROSCIENCE (2016)
Diabetes-Induced Oxidative Stress in Endothelial Progenitor Cells May Be Sustained by a Positive Feedback Loop Involving High Mobility Group Box-1
Han Wu et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2016)
Therapeutic potential of the dual peroxisome proliferator activated receptor (PPAR)α/γ, agonist aleglitazar in attenuating TNF-α-mediated inflammation and insulin resistance in human adipocytes
Marika Massaro et al.
PHARMACOLOGICAL RESEARCH (2016)
The Role of HMGB1 in the Pathogenesis of Type 2 Diabetes
Yanan Wang et al.
JOURNAL OF DIABETES RESEARCH (2016)
Sterile inflammation and pregnancy complications: a review
Mathieu Nadeau-Vallee et al.
REPRODUCTION (2016)
Cardiomyocyte-fibroblast interaction contributes to diabetic cardiomyopathy in mice: Role of HMGB1/TLR4/IL-33 axis
Aibin Tao et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2015)
PPARγ-Dependent and -Independent Inhibition of the HMGB1/TLR9 Pathway by Eicosapentaenoic Acid Attenuates Ischemic Brain Damage in Ovariectomized Rats
Manabu Sumiyoshi et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2015)
Plasma HMGB-1 Levels in Subjects with Obesity and Type 2 Diabetes: A Cross-Sectional Study in China
Hang Wang et al.
PLOS ONE (2015)
Anti-HMGB1 antibody reduces weight gain in mice fed a high-fat diet
V. N. Montes et al.
NUTRITION & DIABETES (2015)
PPARγ-Dependent and -Independent Inhibition of the HMGB1/TLR9 Pathway by Eicosapentaenoic Acid Attenuates Ischemic Brain Damage in Ovariectomized Rats
Manabu Sumiyoshi et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2015)
The role of oxidative stress during inflammatory processes
Jerome Lugrin et al.
BIOLOGICAL CHEMISTRY (2014)
Regulation of high mobility group box 1 and hypoxia in the migration of mesenchymal stem cells
Hong-Lei Xie et al.
CELL BIOLOGY INTERNATIONAL (2014)
RAGE Regulates the Metabolic and Inflammatory Response to High-Fat Feeding in Mice
Fei Song et al.
DIABETES (2014)
Inhibition of high-mobility group box 1 improvesmyocardial fibrosis and dysfunction in diabetic cardiomyopathy
Wen-ke Wang et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2014)
HMGB1 mediates hyperglycaemia-induced cardiomyocyte apoptosis via ERK/Ets-1 signalling pathway
Wen-Ke Wang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2014)
A Systematic Nomenclature for the Redox States of High Mobility Group Box (HMGB) Proteins
Daniel J. Antoine et al.
MOLECULAR MEDICINE (2014)
The Role of HMGB1 in the Pathogenesis of Inflammatory and Autoimmune Diseases
Melinda Magna et al.
MOLECULAR MEDICINE (2014)
An overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1-related pathologies
Domenica Musumeci et al.
PHARMACOLOGY & THERAPEUTICS (2014)
PKM2 regulates the Warburg effect and promotes HMGB1 release in sepsis
Liangchun Yang et al.
NATURE COMMUNICATIONS (2014)
Assembly and localization of Toll-like receptor signalling complexes
Nicholas J. Gay et al.
NATURE REVIEWS IMMUNOLOGY (2014)
Insulin infusion suppresses while glucose infusion induces Toll-like receptors and high-mobility group-B1 protein expression in mononuclear cells of type 1 diabetes patients
Paresh Dandona et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2013)
HMGB1 in Cancer: Good, Bad, or Both?
Rui Kang et al.
CLINICAL CANCER RESEARCH (2013)
Inflammatory Markers and Risk of Type 2 Diabetes A systematic review and meta-analysis
Xia Wang et al.
DIABETES CARE (2013)
Diabetic retinopathy: pathogenesis, clinical grading, management and future developments
L. Z. Heng et al.
DIABETIC MEDICINE (2013)
High-mobility group protein B1: a new biomarker of metabolic syndrome in obese children
Teresa Arrigo et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2013)
RAGE and TLRs: Relatives, friends or neighbours?
Zaridatul Aini Ibrahim et al.
MOLECULAR IMMUNOLOGY (2013)
HMGB1 and leukocyte migration during trauma and sterile inflammation
Emilie Venereau et al.
MOLECULAR IMMUNOLOGY (2013)
Signaling of High Mobility Group Box 1 (HMGB1) through Toll-like Receptor 4 in Macrophages Requires CD14
Sodam Kim et al.
MOLECULAR MEDICINE (2013)
Soluble HMGB1 Is a Novel Adipokine Stimulating IL-6 Secretion through RAGE Receptor in SW872 Preadipocyte Cell Line: Contribution to Chronic Inflammation in Fat Tissue
Brice Nativel et al.
PLOS ONE (2013)
Conditional ablation of HMGB1 in mice reveals its protective function against endotoxemia and bacterial infection
Hideyuki Yanai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Paucity of CD34-positive cells and increased expression of high-mobility group box 1 in coronary thrombus with type 2 diabetes mellitus
Atsushi Yamashita et al.
ATHEROSCLEROSIS (2012)
Pancreatic β Cell Dedifferentiation as a Mechanism of Diabetic β Cell Failure
Chutima Talchai et al.
CELL (2012)
HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4
Milena Schiraldi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release
Emilie Venereau et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
A Janus Tale of Two Active High Mobility Group Box 1 (HMGB1) Redox States
Daolin Tang et al.
MOLECULAR MEDICINE (2012)
被撤回的出版物: Redox Modification of Cysteine Residues Regulates the Cytokine Activity of High Mobility Group Box-1 (HMGB1) (Publication with Expression of Concern. See vol. 26, 2020) (Retracted article. See vol. 26, 2020)
Huan Yang et al.
MOLECULAR MEDICINE (2012)
The high mobility group box: the ultimate utility player of a cell
Christopher S. Malarkey et al.
TRENDS IN BIOCHEMICAL SCIENCES (2012)
Hyperlipidemia stimulates the extracellular release of the nuclear high mobility group box 1 protein
Raluca Haraba et al.
CELL AND TISSUE RESEARCH (2011)
Therapeutic Potential of High Mobility Group Box-1 in Ischemic Injury and Tissue Regeneration
Federico Biscetti et al.
CURRENT VASCULAR PHARMACOLOGY (2011)
Toll-like receptors on the fork roads between innate and adaptive immunity
Ahmed Abdelsadik et al.
HUMAN IMMUNOLOGY (2011)
Septic Shock Is Associated with Receptor for Advanced Glycation End Products Ligation of LPS
Yasuhiko Yamamoto et al.
JOURNAL OF IMMUNOLOGY (2011)
HMGB1 A novel Beclin 1-binding protein active in autophagy
Rui Kang et al.
AUTOPHAGY (2010)
HMGB1: the missing link between diabetes mellitus and heart failure
H. Christian Volz et al.
BASIC RESEARCH IN CARDIOLOGY (2010)
The alarmin functions of high-mobility group proteins
De Yang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2010)
Increased Toll-Like Receptor (TLR) Activation and TLR Ligands in Recently Diagnosed Type 2 Diabetic Subjects
Mohan R. Dasu et al.
DIABETES CARE (2010)
High-mobility group box 1 is involved in the initial events of early loss of transplanted islets in mice
Nobuhide Matsuoka et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Complement C3a, CpG Oligos, and DNA/C3a Complex Stimulate IFN-α Production in a Receptor for Advanced Glycation End Product-Dependent Manner
Benfang Helen Ruan et al.
JOURNAL OF IMMUNOLOGY (2010)
Circulating high-molecular-weight RAGE ligands activate pathways implicated in the development of diabetic nephropathy
Sally A. Penfold et al.
KIDNEY INTERNATIONAL (2010)
A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release
Huan Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Current Views of Toll-Like Receptor Signaling Pathways
Masahiro Yamamoto et al.
GASTROENTEROLOGY RESEARCH AND PRACTICE (2010)
Multiple levels of regulation determine the role of the receptor for AGE (RAGE) as common soil in inflammation, immune responses and diabetes mellitus and its complications
A. Bierhaus et al.
DIABETOLOGIA (2009)
Free Fatty Acids Induce a Proinflammatory Response in Islets via the Abundantly Expressed Interleukin-1 Receptor I
Marianne Boeni-Schnetzler et al.
ENDOCRINOLOGY (2009)
RAGE: therapeutic target and biomarker of the inflammatory response-the evidence mounts
Ravichandran Ramasamy et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
RAGE-induced Cytosolic ROS Promote Mitochondrial Superoxide Generation in Diabetes
Melinda T. Coughlan et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Extracellular high-mobility group box 1 acts as an innate immune mediator to enhance autoimmune progression and diabetes onset in NOD mice
Junyan Han et al.
DIABETES (2008)
Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes
Aino Soro-Paavonen et al.
DIABETES (2008)
Induction of immunological tolerance by apoptotic cells requires caspase-dependent oxidation of high-mobility group box-1 protein
Hirotaka Kazama et al.
IMMUNITY (2008)
Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE(-/-) mice
Evis Harja et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Pathogenic role of NF-κB activation in tubulointerstitial inflammatory lesions in human lupus nephritis
Ling Zheng et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2008)
RAGE ligation affects T cell activation and controls T cell differentiation
Yali Chen et al.
JOURNAL OF IMMUNOLOGY (2008)
Signaling to NF-κB by Toll-like receptors
Taro Kawai et al.
TRENDS IN MOLECULAR MEDICINE (2007)
A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA
Stanimir Ivanov et al.
BLOOD (2007)
Toll-like receptor 4 suppression leads to islet allograft survival
Alyssa Goldberg et al.
FASEB JOURNAL (2007)
The heterogeneity of diabetes - Unraveling a dispute: Is systemic inflammation related to islet autoimmunity?
Massimo Pietropaolo et al.
DIABETES (2007)
HMGB1 expression by activated vascular smooth muscle cells in advanced human atherosclerosis plaques
Katsumi Inoue et al.
CARDIOVASCULAR PATHOLOGY (2007)
Requirement of MyD88 for macrophage-mediated islet xenograft rejection after adoptive transfer
Shounan Yi et al.
TRANSPLANTATION (2007)
Blockade of RAGE suppresses alloimmune reactions in vitro and delays allograft rejection in murine heart transplantation
B. Moser et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2007)
Effects of magnolol (5,5'-diallyl-'2,2'-dihydroxybiphenyl) on diabetic nephropathy in type 2 diabetic Goto-Kakizaki rats
Eun Jin Sohn et al.
LIFE SCIENCES (2007)
High mobility group box-1 protein induces the migration and activation of human dendritic cells and acts as an alarmin
De Yang et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
The secretion of HMGB1 is required for the migration of maturing dendritic cells
Ingrid E. Dumitriu et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules
Dirk Foell et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
Dietary AGEs and ALEs and risk to human health by their interaction with the receptor for advanced glycation endproducts (RAGE) - an introduction
Paul J. Thornalley
MOLECULAR NUTRITION & FOOD RESEARCH (2007)
Arguing for the motion: Yes, RAGE is a receptor for advanced glycation endproducts
Ravichandran Ramasamy et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2007)
The mechanism by which dietary AGEs are a risk to human health is via their interaction with RAGE: Arguing against the motion
Claus W. Heizmann
MOLECULAR NUTRITION & FOOD RESEARCH (2007)
Mechanisms linking obesity to insulin resistance and type 2 diabetes
Steven E. Kahn et al.
NATURE (2006)
Dendritic cell activating peptides induce distinct cytokine profiles
Gloria Telusma et al.
INTERNATIONAL IMMUNOLOGY (2006)
Cardiac troponin I but not cardiac troponin T induces severe autoimmune inflammation in the myocardium
Stefan Goeser et al.
CIRCULATION (2006)
Activation of sPLA2-IIA and PGE2 production by high mobility group protein B1 in vascular smooth muscle cells sensitized by IL-1β
Amandine Jaulmes et al.
FASEB JOURNAL (2006)
High mobility group box 1 protein interacts with multiple Toll-like receptors
JS Park et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2006)
A deficiency in the in vivo clearance of apoptotic cells is a feature of the NOD mouse
BA O'Brien et al.
JOURNAL OF AUTOIMMUNITY (2006)
Cutting edge: Extracellular high mobility group box-1 protein is a proangiogenic cytokine
S Mitola et al.
JOURNAL OF IMMUNOLOGY (2006)
The cytokine activity of HMGB1
H Yang et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2005)
Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products
IE Dumitriu et al.
JOURNAL OF IMMUNOLOGY (2005)
Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of IKKβ
MS Yuan et al.
SCIENCE (2001)
Share Paper
